Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows from Operating Activities:
Net income	$ 3,465	$ 3,256
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	829	888
Provision for bad debts	$ 418	506
Compensatory element of stock issuances		53
Stock issued for costs and expenses		76
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	$ (2,186)	(2,111)
Notes receivable	$ 11	81
Costs and estimated earnings in excess of billings on uncompleted contracts		(860)
Inventories	$ (104)	22
Prepaid expenses and other current assets	73	284
Other assets	12	(5)
Increase (decrease) in operating liabilities, net:
Accounts payable	(187)	323
Other current liabilities	1,120	865
Customer deposits	1	(357)
Other liabilities	16	(123)
Due to related medical practices	(4)	(6)
Net cash provided by operating activities	3,464	2,892
Cash Flows from Investing Activities:
Purchases of property and equipment	(45)	(26)
Cost of patents	(19)	(46)
Net cash used in investing activities	(64)	(72)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(623)	(921)
Distributions to noncontrolling interests	(1,255)	(1,191)
Repayment of notes receivable from employee stockholders	2	2
Net cash used in financing activities	(1,876)	(2,110)
Net Increase in Cash and Cash Equivalents	1,524	710
Cash and Cash Equivalents - Beginning of Period	9,449	9,952
Cash and Cash Equivalents - End of Period	$ 10,973	$ 10,662